Resultados de la búsqueda 281-290 of 8859 for Assay

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay. A database of paired clinical and sequencing data will also be established for future research. Inotuzumab Ozogamicin And Post-Induction Chemotherapy ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  8. Prueba de la enfermedad de Parkinson (ensayo de amplificación de semillas de a-sinucleína) - Mayo Clinic

    a-Synuclein seed amplification assays in the diagnosis of synucleinopathies using cerebrospinal fluid — A systematic review and meta-analysis. Movement ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...